Gastroenterologydrug-induced liver injuryDILI
Navigating Drug-Induced Liver Injury in Clinical Trials: Insights and Updates from FDA Experts
By MedXY|Sep 7, 2026
Drug-Induced Liver Injury (DILI) remains a pivotal challenge in drug development, with evolving drug modalities and clinical trial designs prompting updated regulatory perspectives from FDA specialists.